Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

P-cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation.

Clinical cancer research : an official journal of the American Association for Cancer Research - 15 Aug 2005

Paredes Joana, Albergaria André, Oliveira João T, Jerónimo Carmen, Milanezi Fernanda, Schmitt Fernando C

Abstract excerpt

PURPOSE: P-cadherin overexpression has been reported in breast carcinomas, where it was associated with proliferative high-grade histological tumors. This study aimed to analyze P-cadherin expression in invasive breast cancer and to correlate it with tumor markers, pathologic features, and patient survival. Another purpose was to evaluate the P-cadherin promoter methylation pattern as the molecular mechanism...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Azacitidine
Share to Cadherins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Decitabine

Share to Ki-67 Antigen

Share to Neoplasm Invasiveness

Share to Receptor, ErbB-2

Share to Receptors, Estrogen

Share to Survival Analysis

Source

Identifiers

PMID: 16115928
DOI: 10.1158/1078-0432.CCR-05-0059

Genes

CDH3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

P-cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation.PMID 16115928Read ↗

Loss of Expression and Aberrant Methylation of the CDH1 (E-cadherin) Gene in Breast Cancer Patients from KashmirSemantic proximity Read ↗

E‐cadherin deregulation in breast cancerSemantic proximity Read ↗

P-cadherin expression in gastric carcinoma: its regulation mechanism and prognostic significance.Semantic proximity Read ↗

Negative/low HER2 expression alone or combined with E-cadherin positivity is predictive of better prognosis in patients with breast carcinoma.Semantic proximity Read ↗

<i>E-cadherin</i>Gene Promoter Hyper-methylation in Blood Samples from Breast Cancer CasesSemantic proximity Read ↗

The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression.Semantic proximity Read ↗

A Systematic Analysis of the Relationship of CDH13 Promoter Methylation and Breast Cancer Risk and Prognosis.Semantic proximity Read ↗

The role of E-cadherin down-regulation in oral cancer: CDH1 gene expression and epigenetic blockage.Semantic proximity Read ↗

Multiple ways of silencing E-cadherin gene expression in lobular carcinoma of the breast.Semantic proximity Read ↗

Mechanisms of inactivation of E-cadherin in breast cancer cell lines.Semantic proximity Read ↗

Combined analysis of E-cadherin gene (CDH1) promoter hypermethylation and E-cadherin protein expression in patients with gastric cancer: implications for treatment with demethylating drugsSemantic proximity Read ↗

Prognostic Analysis of E-Cadherin Gene Promoter Hypermethylation in Patients with Surgically Resected, Node-Positive, Diffuse Gastric CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.